ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,340, issued on April 21, was assigned to ZIM LABORATORIES Ltd. (Maharashtra, India).

"Extended release composition of 2-(2-Aminothiazol-4-yl)-N-[4-(2{[(2R)-2-hydroxy-2-phenylethyl amino} ethyl) phenyl acetamide" was invented by Anwar Daud (Maharashtra, India), Chandrashekhar Mainde (Maharashtra, India), Uttam Kedar (Maharashtra, India) and Kuldeep Gangawat (Maharashtra, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to extended release composition of Mirabegron and process of manufacture thereof. The extended release composition of mirabegron comprising non-polymeric hydrophobic excipient as release controlling a...